FilingReader Intelligence

Betta Pharmaceuticals shareholder extends share pledge

June 18, 2025 at 05:09 PM UTCBy FilingReader AI

Betta Pharmaceuticals (SZSE:300558) announced that shareholder Kai Ming Investment Management Partnership (Kai Ming Investment) has extended a share pledge of 6,055,000 shares, representing 7.56% of its holdings and 1.44% of Betta's total share capital. Originally set to mature on June 20, 2025, the pledge has been extended to June 20, 2026, with Guoyuan Securities as the pledgee. This extension is for Kai Ming Investment’s own capital arrangements and does not involve new financing. Kai Ming Investment's repayment ability is supported by self-owned funds and investment income. As of the announcement, Kai Ming Investment and its consistent actors have accumulatively pledged 53,079,904 shares.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Betta Pharmaceuticals publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →